← Back to headlines
TechCreate appeals NYSE American delisting decision
Biotech firm TechCreate has announced plans to formally challenge the NYSE American's delisting order, citing procedural concerns and exploring alternative listing venues while continuing operations.
Sources
Showing 0 of 1 sources
No articles available in your preferred languages.
1 article available in other languages below.
